Airam De Burgos

BIFAP, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain, Spain

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Risk of Ischemic Stroke Associated with DOAC Discontinuation on Patients with Non-valvular Atrial Fibrillation

  Saturday, August 27, 2022
  2:00 PM – 2:15 PM CEST